Definitive Healthcare Stock

Definitive Healthcare ROE

The Return on Equity (ROE) of Definitive Healthcare (DH) as of Aug 14, 2026 is -49.42 %. In the previous year, Return on Equity (ROE) was -92.97 % — a change of -46.84% (higher).

ROE

-49.42 %

YoY

-46.84%

Last updated:

In 2026, Definitive Healthcare's return on equity (ROE) was -49.42 %, a -46.84% increase from the -92.97 % ROE in the previous year.

Access this data via the Eulerpool API

Definitive Healthcare Stock analysis

What does Definitive Healthcare do? Definitive Healthcare Corp is a leading provider of software and information for companies in the healthcare industry. The company was founded in 2011 and is headquartered in Framingham, Massachusetts. Since its founding, the company has become one of the major providers of data and analysis in the healthcare industry. The business model of Definitive Healthcare is based on providing comprehensive information and analysis for companies operating in the healthcare industry. This includes pharmaceutical and medical technology companies, as well as hospitals, clinics, and insurance companies. With the help of Definitive Healthcare's data and analysis, these companies can make better decisions and develop informed strategies. Definitive Healthcare is divided into different segments to meet the varying needs of its customers. One of these segments is the provider segment, where information about healthcare facilities is collected and provided. Another segment is the pharmaceutical and biotech segment, where pharmaceutical companies can learn more about their customers and their needs. For the medical technology segment, information and analysis on the habits of their customers are provided. Definitive Healthcare offers a variety of products that make it easier for its customers to achieve their business goals. One of the company's most important products is the Definitive Healthcare Platform Dashboard. The dashboard provides a comprehensive overview of the entire healthcare market and informs about the latest trends and developments. Another important product is the Definitive Medtech Suite, a platform that provides analysis and information for the medical technology segment. Other products of Definitive Healthcare include the Definitive Pharmacy & Clinical Suite, which provides information and analysis for the pharmaceutical and biotech segment. The suite also includes a database of information on drugs and their usage. Another important product is the Definitive Hospital Insights Suite, which contains information about hospitals and healthcare facilities. Definitive Healthcare has gained a good reputation in the industry and is now one of the major providers of data and analysis in the healthcare industry. The company is constantly striving to improve its products and services and provide its customers with a useful and relevant source of information. The focus of Definitive Healthcare is on providing data and analysis that help companies in the industry make informed decisions and achieve their business goals. Definitive Healthcare is one of the most popular companies on Eulerpool.

ROE Details

Decoding Definitive Healthcare's Return on Equity (ROE)

Definitive Healthcare's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Definitive Healthcare's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Definitive Healthcare's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Definitive Healthcare’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Definitive Healthcare stock

Return on Equity (ROE) of Definitive Healthcare is -49.42 % in 2026.

Return on Equity (ROE) of Definitive Healthcare changed from -92.97 % to -49.42 %, representing a -46.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Definitive Healthcare since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Definitive Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Definitive Healthcare

All Key Metrics — Definitive Healthcare